表观遗传调控在糖尿病视网膜病变氧化应激中的作用
研究探讨表观遗传机制如何调控糖尿病视网膜病变中Rac1介导的氧化应激。在体外高糖处理的人视网膜内皮细胞及链脲佐菌素诱导的糖尿病小鼠视网膜微血管中,发现Dnmt1结合增加但5mC水平低于正常,同时5hmC和NF-κB结合增加;抑制Dnmt/Tet可减弱Rac1激活,玻璃体腔注射Dnmt1-siRNA可改善小鼠Rac1转录与活性并降低ROS水平。
要点
- 高糖下Rac1启动子Dnmt1结合增加但5mC水平低于正常。
- 同一位点5hmC和NF-κB结合增加,抑制Dnmt/Tet可减弱Rac1激活。
- 小鼠玻璃体腔Dnmt1-siRNA降低Rac1转录、活性及ROS水平。
核心结论
- 尽管Dnmts被激活,Tets concomitantly增加使5mC快速羟甲基化,允许NF-κB结合并激活Rac1。
- 活跃的DNA甲基化在糖尿病视网膜病变胞质ROS调控中起关键作用。
研究设计与样本
- 体外研究使用人视网膜内皮细胞暴露于高糖,定量Rac1启动子5mC、5hmC水平及Dnmt/Tet结合。
- 通过药理学抑制剂或siRNA抑制Dnmts/Tets,评估对葡萄糖诱导Rac1-ROS产生的影响。
- 体内验证使用链脲佐菌素诱导的糖尿病小鼠视网膜微血管,玻璃体腔注射Dnmt1-siRNA。
主要发现
- 高糖诱导Dnmt1结合增加,但Rac1启动子5mC水平保持低于正常。
- 同一位点5hmC水平和转录因子NF-κB结合增加。
- 抑制Dnmts/Tets阻止5hmC和NF-κB结合增加,并减弱Rac1激活。
- 小鼠视网膜微血管中,Dnmt1-siRNA改善糖尿病诱导的Rac1转录和活性增加,并降低ROS水平。
临床怎么用
- 提示靶向Dnmt1/Tet介导的Rac1启动子羟甲基化可能成为糖尿病视网膜病变抗氧化应激策略。
- Dnmt1-siRNA在动物模型中降低Rac1活性和ROS,支持表观遗传干预潜力。
局限性
- 机制研究主要基于体外细胞和链脲佐菌素小鼠模型,尚未在人类患者中验证。
- 未报告临床样本量、P值或置信区间等统计细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Oxidative stress plays a central role in the development of diabetic retinopathy, and in the pathogenesis of this blinding disease, activation of NADPH oxidase 2 (Nox2)-mediated cytosolic reactive oxygen species (ROS) production precedes mitochondrial damage. The multicomponent cytosolic Nox2 has an obligatory component, Ras-related C3 botulinum toxin substrate 1 (Rac1); in diabetes, Rac1 is functionally and transcriptionally active. Diabetes also facilitates many epigenetic modifications, and activates both DNA methylating (Dnmts) and hydroxymethylating (Tets) enzymes. Our aim was to investigate the role of epigenetics in Rac1 regulation in diabetes. METHODS: Using human retinal endothelial cells, exposed to high glucose, 5-methyl cytosine (5mC) and 5-hydroxy methyl cytosine (5hmC) levels, and binding of Dnmt and Tets were quantified at the Rac1 promoter. The effect of inhibition of Dnmts/Tets (pharmacological inhibitors or short interfering RNA [siRNA]) on glucose-induced activation of Rac1-ROS production was evaluated. Results were confirmed in retinal microvessels from streptozotocin-induced diabetic mice receiving intravitreally Dnmt1-siRNA. RESULTS: Despite high glucose-induced increased binding of Dnmt1, 5mC levels remained subnormal at Rac1 promoter. But, at the same site, 5hmC levels and transcription factor nuclear factor (NF)-kB binding were increased. Inhibition of Dnmts/Tets prevented increase in 5hmC and NF-kB binding, and attenuated Rac1 activation. Similarly, in mouse retinal microvessels, Dnmt1-siRNA ameliorated diabetes-induced increase in Rac1 transcripts and activity, and decreased ROS levels. CONCLUSIONS: Thus, despite Dnmts activation, concomitant increase in Tets rapidly hydroxymethylates 5mC, allowing NF-κB to bind and activate Rac1. These results imply a critical role of an active DNA methylation in cytosolic ROS regulation in the development of diabetic retinopathy.
引用
- Duraisamy AJ, Mishra M, Kowluru A, et al. Epigenetics and Regulation of Oxidative Stress in Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2018. PMID: 30347077. doi:10.1167/iovs.18-24548
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。